Find the Perfect Plan for Your Investment Journey
Last Price
52 Week Range
$4.25 - $16.74
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Last Price
Market Cap | $1.13B |
EV | $857.79M |
Shares Outstanding | 166.59M |
Beta | -0.94 |
Analyst Rating | BUY |
Analyst Target Price | $21.31 |
P/E 2025E | - |
P/Revenue 2025E | 16.04x |
Revenue | 38.30% |
EPS | 33.30% |
Operating Cash Flow | -19.30% |
Free Cash Flow | -19.30% |
Revenue | 13.00% |
EPS | 1.50% |
Operating Cash Flow | -3.80% |
Free Cash Flow | -13.20% |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -235.61% |
ROE 2025E | -72.30% |
ROCE 2024 | -77.87% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Wave Life Sciences Ltd.
WVE
Sector
Healthcare
Industry
Biotechnology
CEO
Bolno, Paul B.
Employees
288
Website
www.wavelifesciences.comIPO Date
2015-11-11
Headquarters
Marina One East Tower, 7 Straits View No.12-00, Singapore 018936, Singapore
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved